Literature DB >> 1434837

Prognostic factors for selecting curative therapy for adult acute myeloid leukemia.

C D Bloomfield1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1434837

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein.

Authors:  B Lutterbach; D Sun; J Schuetz; S W Hiebert
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 2.  AIDS related systemic non-Hodgkin's lymphoma.

Authors:  T Powles; G Matthews; M Bower
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

3.  Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.

Authors:  Shakil H Merchant; Skip Haines; Bryan Hall; John Hozier; David S Viswanatha
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

4.  Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.

Authors:  Eun Kyung Cho; Soo Mee Bang; Jeong Yeal Ahn; Seung Min Yoo; Pil Whan Park; Yieh Hea Seo; Dong Bok Shin; Jae Hoon Lee
Journal:  Korean J Intern Med       Date:  2003-03       Impact factor: 2.884
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.